ProjectUCB SP0982 – Interview für die Studie SP0982
Basic data
Acronym:
UCB SP0982
Title:
Interview für die Studie SP0982
Duration:
09/04/2015 to 09/04/2015
Abstract / short description:
Protocol SP0982:
A double-blind, randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy and safety of lacosamide as adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in subjects with idiopathic generalized eilepsy.
A double-blind, randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy and safety of lacosamide as adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in subjects with idiopathic generalized eilepsy.
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Martinsried, Bayern, Germany